[1] Major FJ, Blessing JA, Silverberg SG,et al.Prognostic factors in early stage uterine sarcoma: a Gynecologic Oncology Group study[J]. Cancer 1993,71:1702-1709.[2] 曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:2101-2113[3] 庞厚清,杨太珠,杨帆,等.子宫肉瘤36例超声诊断分析[J].实用癌症杂志,2006,21(6):620[4] Chan JK, Kawar NM, Shin JY,et al.Endometrial stromal sarcoma:a population-based analysis[J].Br J Cancer,2008,99(8):1210-1215.[5] Nemani D,Mitra N,Guo M,et al.Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma:a SEER analysis[J].Gynecol Oncol,2008,111(1):82-88.[6] Kapp DS,Shin JY,Chan JK,et al.Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas:emphasis on impact of lymphadenectomy and oophorectomy[J]. Cancer, 2008,112(4):820-830.[7] Shah JP,Bryant CS,Kumar S,et al.Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma[J].Obstet Gynecol,2008,112(5):1102-1108.[8] Lurian FR,Piver MS.Uterine sarcomas:clinical feature and management[J].Gynecol Oncol,1992,46(2):820-840.(2014-05-05收稿 2014-08-05修回) |